טוען...
Antiepileptic drugs for the treatment of infants with severe myoclonic epilepsy
BACKGROUND: This is an updated version of the original Cochrane review published in 2015, Issue 10. Severe myoclonic epilepsy in infants (SMEI), also known as Dravet syndrome, is a rare, refractory form of epilepsy, for which stiripentol (STP) has been recently licensed as add‐on therapy. OBJECTIVES...
שמור ב:
| הוצא לאור ב: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
John Wiley & Sons, Ltd
2017
|
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6481545/ https://ncbi.nlm.nih.gov/pubmed/28521067 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010483.pub4 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|